|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Talaris Therapeutics (NASDAQ: TALS) through any online brokerage.
There are no as such competitors for Talaris Therapeutics.
The latest price target for Talaris Therapeutics (NASDAQ: TALS) was reported by Morgan Stanley on June 1, 2021. The analyst firm set a price target for 35.00 expecting TALS to rise to within 12 months (a possible 106.49% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Talaris Therapeutics (NASDAQ: TALS) is $16.95 last updated Fri Jun 18 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Talaris Therapeutics.
There is no upcoming split for Talaris Therapeutics.
Talaris Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.